Aspirin-exacerbated respiratory disease and the Unified Airway: a contemporary review
BK Walters, JB Hagan, RD Divekar… - … Clinics of North …, 2023 - oto.theclinics.com
An estimated 1.4 million Americans are currently diagnosed with AERD, 3 although the
actual number may be much higher, as any part of the diagnostic triad may be present but …
actual number may be much higher, as any part of the diagnostic triad may be present but …
Controversies in allergy: aspirin desensitization or biologics for aspirin-exacerbated respiratory disease—how to choose
TM Laidlaw, DK Chu, WW Stevens, AA White - The Journal of Allergy and …, 2022 - Elsevier
Aspirin-exacerbated respiratory disease (AERD) can be a frustratingly complex syndrome to
treat. Until recently, standard medical and surgical therapies for patients' asthma and chronic …
treat. Until recently, standard medical and surgical therapies for patients' asthma and chronic …
Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease (AERD)?
TM Laidlaw, AA White - The Journal of Allergy and Clinical Immunology: In …, 2023 - Elsevier
Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory
Disease (AERD)? Page 1 Journal Pre-proof Should Biologics Be Used Before Aspirin …
Disease (AERD)? Page 1 Journal Pre-proof Should Biologics Be Used Before Aspirin …
What's new in the diagnosis and treatment of aspirin-exacerbated respiratory disease: a brief review
JE Douglas, JV Bosso - American Journal of Rhinology & …, 2023 - journals.sagepub.com
Background Aspirin-exacerbated respiratory disease (AERD) is a chronic condition
characterized by the presence of asthma, chronic rhinosinusitis with nasal polyposis, and …
characterized by the presence of asthma, chronic rhinosinusitis with nasal polyposis, and …
Aspirin-exacerbated respiratory disease: Updates in the era of biologics
J Mullur, KM Buchheit - Annals of Allergy, Asthma & Immunology, 2023 - Elsevier
Objective Aspirin-exacerbated respiratory disease (AERD) is a chronic respiratory condition
characterized by severe chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic …
characterized by severe chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic …
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
SH Tripathi, A Corr, A Kumar… - Allergy & Asthma …, 2023 - search.ebscohost.com
Background: Aspirin exacerbated respiratory disease (AERD) is an inflammatory condition
that consists of eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and respiratory …
that consists of eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and respiratory …
Is endoscopic sinus surgery sufficient to modify the evolution of adult AERD? Aspirin desensitization as a maintenance factor: systematic review
DM Conti, EJ Correa, GK Scadding - Frontiers in Allergy, 2023 - frontiersin.org
Introduction Aspirin desensitization (AD) and aspirin therapy after desensitization (ATAD)
are therapeutic interventions for patients with aspirin-exacerbated respiratory disease …
are therapeutic interventions for patients with aspirin-exacerbated respiratory disease …
Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
EK O'Brien, E Jerschow… - Otolaryngologic Clinics of …, 2024 - oto.theclinics.com
Aspirin-exacerbated respiratory disease (AERD) is a subtype of chronic rhinosinusitis with
polyps (CRSwNP) with asthma and upper and/or lower airway reactions after ingestion of …
polyps (CRSwNP) with asthma and upper and/or lower airway reactions after ingestion of …
[HTML][HTML] Hereditary angioedema again revisited
JA Bellanti, RA Settipane - Allergy and Asthma Proceedings, 2021 - ncbi.nlm.nih.gov
" Hereditary angioedema revisited," 1 which referred to our previous editorial written in the
September 2011 issue entitled" Hereditary angioedema: an instructive model of clinical …
September 2011 issue entitled" Hereditary angioedema: an instructive model of clinical …